French MPs Back Outright Ban on Neonics

France’s lower house of the country’s parliament, Assemblée Nationale (National Assembly), has voted to place an outright ban on the use of all neonicotinoid insecticides in the country from Sept. 1, 2018.

At the same time, farm minister, Stéphane Le Foll, said France would call on the European Commission to apply these restrictions to all of the EU.

The proposed ban, part of a draft biodiversity bill, will go to the French Senate for further review before the Assembly takes its final vote on the matter, expected this summer.

In a statement, the French government called banning neonics “a responsible solution that provides the necessary time to assess alternatives, in terms of their pest control effectiveness and health and environmental impacts, particularly on bees.”

France had been considering a ban on all neonicotinoid insecticides from Jan. 1, 2017, but this would have required the use of other insecticides that have not been proven to be less toxic for the environment and bees, the government said.

France has often taken the lead in Europe on banning controversial substances, including bisphenol A (BPA), used in production of polycarbonate or epoxy resin can liners, which some suspect of being an endocrine disruptor.

A temporary EU-wide ban on use of neonicotinoid seed treatments for crops attractive to bees, took effect in December 2013. In some cases, the UK government recently has granted farmers exceptions.

In addition to their use in sugar beet, neonicotinoid active substances remain available for use in cereal seed treatments and as foliar sprays for control of pollen beetle in oilseed rape and aphids in a range of crops.

In the UK, the sugar beet research and advisory organization British Beet Research Organization (BBRO) has gone on record as saying that banning neonics would have “enormous” consequences for sugar beet production.

The organization has already commissioned research projects seeking alternative strategies to neonicotinoid use in sugar beet, including developing varieties with improved resistance to pests and disease, but has stressed that these would take time to reach commercial use.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.